Recombinant PDCD1 (Nivolumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all PDCD1 (Nivolumab Biosimilar) products
- PDCD1 (Nivolumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This PDCD1 (Nivolumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Nivolumab Biosimilar - Anti-PD1 mAb
- Characteristics
- Antibody Type: IgG4
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG4
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- 4 °C,-20 °C
- Storage Comment
- 4°C for short term, -20°C for long term
-
- Target
- PDCD1 (Nivolumab Biosimilar)
- Abstract
- PDCD1 (Nivolumab Biosimilar) Products
- Synonyms
- CD279 antibody, PD-1 antibody, PD1 antibody, SLEB2 antibody, hPD-1 antibody, hPD-l antibody, programmed cell death 1 antibody, PDCD1 antibody
- Target Type
- Biosimilar
- Background
-
Nivolumab
Nivolumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
-
You are here:
